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Abstract
The transition between morula and blastocyst stage during preimplantation development represents the first differentiation
event of embryogenesis. Morula cells undergo the first cellular specialization and produce two well-defined populations of
cells, the trophoblast and the inner cell mass (ICM). Embryonic stem cells (ESCs) with unlimited self-renewal capacity are
believed to represent the in vitro counterpart of the ICM. Both mouse and rat ESCs can be derived from the ICM cells, but
their in vitro stability differs. In this study we performed a microarray analysis in which we compared the transcriptome of
mouse and rat morula, blastocyst, and ICM. This cross-species comparison represents a good model for understanding the
differences in derivation and cultivation of ESCs observed in the two species. In order to identify alternative regulation of
important molecular mechanisms the investigation of differential gene expression between the two species was extended
at the level of signaling pathways, gene families, and single selected genes of interest. Some of the genes differentially
expressed between the two species are already known to be important factors in the maintenance of pluripotency in ESCs,
like for example Sox2 or Stat3, or play a role in reprogramming somatic cells to pluripotency like c-Myc, Klf4 and p53 and
therefore represent interesting candidates to further analyze in vitro in the rat ESCs. This is the first study investigating the
gene expression changes during the transition from morula to blastocyst in the rat preimplantation development. Our data
show that in the pluripotent pool of cells of the rat and mouse preimplantation embryo substantial differential regulation of
genes is present, which might explain the difficulties observed for the derivation and culture of rat ESCs using mouse
conditions.
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Introduction
The period of time that lasts from the fertilization of the egg
to the implantation of the blastocyst represents an attractive
model for studying regulatory networks that determine cell fate
decisions. Of particular interest is the transition between morula
and blastocyst stages, which is the period where pluripotent cells
are formed. Morula cells undergo the first cellular specialization
and produce an outer rim of cells, the so-called trophoblast that
surrounds an inner core of cells the inner cell mass (ICM). The
signals that regulate differentiation of the trophectoderm are
largely unknown. One of the key discoveries of the last century
was the observation that after transferring blastocyst stage
embryos in an artificial context it is possible to establish cells,
which retain the pluripotent state. These cells, also known as
embryonic stem cells (ESCs) are derived from the ICM of the
blastocysts [1,2] and exhibit unique characteristics: They
unlimitedly self-renew in vitro and are able to contribute to
the formation of all cells of an adult organism. Understanding
how this population of cells is formed and maintained is of
fundamental importance not only for developmental biology but
also for regenerative medicine and cancer biology. Nowadays,
ESCs are routinely derived from mouse blastocyst embryos,
even though not with any difficulties. The mouse has
represented for many years the sole organism where pluripotent
and germline competent ESCs could be derived. Only recently,
almost 30 years after the establishment of the first mouse ESC
line, genuine rat ESCs have been generated [3,4]. The real
identity and stability of these cells is not yet completely
understood, especially because mouse ESCs and rat ESCs are
derived and cultivated under different conditions. Mouse ESCs
can be maintained in medium containing inhibitors of the
fibroblast growth factor (FGF)/mitogen-activated protein kinase
(MEK)/extracellular signal-related kinase (ERK1/2) and of the
glycogen synthase kinase 3 (GSK3). These culture conditions are
known as the 3i or 2i culture conditions [5] and have been also
used for the successful establishment of mouse ESCs from non-
permissive mouse strains such as the non-obese diabetic (NOD)
mice [6]. Molecularly, rat ESCs express the same pluripotency
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markers like mouse ESCs [3,4] but can be established and
maintained in vitro only under defined culture conditions and
additionally in the presence of LIF and feeders. The difference
between the two species is also mirrored at the preimplantation
development level. Mouse embryos reach the blastocyst stage at
day E3.5 whereas the rat at day E4.5 (Figure 1A), nevertheless
both species give birth at day E21. These differences highlight
the complexity of the mechanisms that define the pluripotent
state of a cell and let to assume that in the rat other molecular
mechanisms might be involved in the maintenance of the
pluripotent state in vitro compared to the mouse.
Extending the knowledge of the molecular processes driving the
establishment of pluripotency in vivo is decisive for understanding
the identity and properties of ESCs in vitro. We therefore reasoned
that a comparison of the gene expression profiles in preimplan-
tation embryos in the mouse and in the rat would be of advantage
for improving the comprehension of the pluripotent state and
eventually for optimizing derivation and cultivation of rat ESCs.
With this purpose we examined and compared with a molecular
genetic approach the global gene expression in morula, blastocyst,
and in isolated ICM of mouse and rat. With this cross species gene
expression comparison we were able to highlight different
regulation not only of important developmental pathways like
Wnt and Notch, but also of genes known to play important roles in
the maintenance of pluripotency in ESCs and in reprogramming
processes like for example Sox2, Klf4, c-Myc and p53.
Results and Discussion
Statement of Grounds and Experimental Design
During early embryogenesis, pluripotency is a characteristic
property of a distinct number of cells of the morula and the ICM
of the blastocyst, from where pluripotent ESCs are established
(Figure 1B). We collected morula and blastocysts stage embryos
from mouse and rat and, by immunosurgery, we isolated the
ICM cells from the blastocysts. All the embryos and ICMs were
pooled into two groups for every developmental stage (Figure 1C).
Pooling of embryos for RNA extraction in this study was chosen
mainly because of the low amounts of RNA that can be isolated
from preimplantation embryos, and in addition because of the
heterogeneity of the cell populations present in the embryos. For
the analysis we pooled a large number (n.100) of the
independent isolated embryos to achieve a sufficient accuracy
of biological pooling (Figure 1C). Due to the difficulties to isolate
a larger number of embryos from mice and rats, we performed
the microarray study by using two replicate samples per
developmental stage (Figure 1D). The global significance analysis
of the mouse and rat expression profiles is depicted on the
Figure 2A and 2B. Top 20 differentially expressed probe sets for
the mouse (Figure 2A) and for the rat (Figure 2B) have been
selected in each of the pairs of treatments and then used at the
input of hierarchical clustering for the heatmap. The heatmap
shows that each pairwise comparison has a group of upregulated
and downregulated genes, however on the global level there is
hardly any overlap in terms of orthologs (just one gene in
common in the heatmap built with over 50 genes from the three
top 20 lists). This leads to the conclusion that prior biological
knowledge should be used for the search of meaningful
relationships. We therefore gathered the information present in
the GeneGo pathways in order to investigate the similarities and
differences locally, within the context of pathways and gene
families.
Identification of Differentially Expressed Genes in the
Three Cell Populations
To reveal similarities and differences in the regulatory
mechanisms controlling mouse and the rat development of morula
and blastocyst, we first analyzed the data of the mouse and the rat
microarray study separately. We selected the genes that had a fold
change (understood as the difference between log2 signal values)
higher than 1.5 in the three comparisons (see Table S1A–C and
S2A–C): ICM versus blastocyst (ICM vs B), blastocyst versus
morula (B vs M), and ICM versus morula (ICM vs M). For the
mouse study we found that out of 179973 genes 166 were
differentially regulated between the ICM and the blastocysts
(Figure 2C and Table S1A). A higher number of differentially
regulated genes was found in the comparison B vs M, where 19621
genes had a fold change higher than 1.5 (Figure 2C and Table
S1B). In the comparison ICM vs M we found 19370 genes, 957 of
which were also differentially expressed between blastocyst and
morula (Figure 2C and Table S1C). Between the 957 genes found
in both the comparisons ICM vs M and B vs M a clear
upregulation of the transcription factor Stat3 and the Lif receptor
Lifr were present. Both genes were upregulated in the blastocyst or
the in ICM compared to the morula but were not differentially
expressed in the comparison ICM vs B (Table S1B and S1C),
confirming their specific expression in the blastocyst. This is
interesting because previous data suggested that the LIF/STAT3
pathway is dispensable during the preimplantation embryo
development in the absence of diapause [7]. Nevertheless, this
pathway plays a fundamental role in vitro in the maintenance of
pluripotency and derivation of ESCs [8,9,10]. Our data highlight
the possibility that the characteristic expression of these genes at
the blastocyst stage might indeed play an important role, and that
the previously performed studies with knockout embryos could
have been biased by the induction of compensatory mechanisms.
Only 23 genes were differentially expressed in both the
comparisons ICM vs B and B vs M (Figure 2C). Between them,
the Celf5 gene, a member of the CELF gene family [11], showed
a 3.5 fold upregulation in the comparison B vs M and a 22.5 fold
downregulation in ICM vs M, indicating a potential function in
the trophoblast cells of the blastocyst.
Aiming at the identification of genes that are very character-
istically expressed in the ICM, we have initially used the strict
threshold on the fold changes (absolute log2 FC.3, see Figure 2D)
The gene Fos had a fold change of 3.5 in the comparison ICM vs B
and 23.9 in the comparison B vs M (Table S1A and S1B)
indicating that Fos expression is high in the morula and persists in
the ICM cells of the blastocyst. Interestingly, it has been shown
that Fos is also expressed in vitro in undifferentiated ESCs and
disappears as soon as the cells undergo differentiation [12]. A
second gene with characteristic ICM expression is Egr1, which was
upregulated 4 times in the comparison ICM vs B and was strongly
downregulated in the comparison B vs M (Table S1C) suggesting
a specific role in the mouse ICM. For the rat study we identified
192 out of 129102 genes that had a fold change higher than 1.5 in
the comparison ICM vs B (Table S2A), among these 71 were also
found differentially regulated in the comparison ICM vs M
(Figure 2E) and 7 of them showed a fold change higher than 3
(Figure 2F). The genes Nqo1, Ddhd1, Hmox1 and Chac1 had
a positive fold change in both the comparisons ICM vs B and ICM
vs M (Table S2C), indicating that they are upregulated exclusively
in the ICM cells of the rat blastocyst. None of these 7 genes was
found in the mouse study in the comparison ICM vs B and ICM vs
M, except for the Nqo1 (NAD(P)H quinone oxidoreductase) that
was upregulated in the ICM compared to the morula, nevertheless
with a factor of 1.5. It has been shown that inhibition of NQO1
Pluripotency Genes in Mouse and Rat Embryos
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causes degradation of p53 in various cell types [13] therefore
NQO1 supports the accumulation of p53, which leads to the
induction of growth arrest [14,15] and/or apoptosis [16].
In a second step we performed a global analysis of these datasets
with the GeneGo software using Metacore annotation database to
assign functional biological processes to each individual species
dataset. For every comparison we selected the 20 more significant
processes present in the 1.5 fold change gene groups (Figure S1).
This analysis highlighted that in the three comparisons there are
different biological processes taking place in the two species. Seen
that the rat preimplantation embryo development is shifted
compared to the mouse of about 24 hours, it is reasonable to
assume that processes like cell cycle or proliferation differs in the
two species at these developmental stages (Figure S1).
In summary, by comparing the gene expression in the morula
and blastocyst from the mouse and from the rat, we demonstrated
that there are differential regulations of factors between the two
species. Further analyses are needed in order to understand if these
genes could have a function in the establishment of ESCs. Of
special interest are those upregulated in the comparison ICM vs B
in the mouse and in the rat, because they might represent new
factors involved in the establishment and maintenance of the ICM
cells, and therefore they might be as well critical factors in the
ESCs.
Cross Species Analysis of Selected Pathways
The purpose of this study was to identify molecular pathways or
genes, which are differentially expressed between the mouse and
the rat, in order to gain insight into the molecular processes
governing pluripotency in the rat. We analyzed fold changes
between mouse and rat in 11 selected pathways from GeneGo
(GeneGo Maps). A list of all the genes and the selected pathways as
well as the gene fold changes is reported in Table S3. For every
comparison (B vs M, ICM vs B, and ICM vs M) we generated
a plot comparing the fold change value of the selected genes in the
mouse with the ones of the same gene in the rat. Every dot
represents a gene. Red dots correspond to genes that have similar
fold change values between the two species. Green dots label genes
with different fold change values between rat and mouse in the
selected comparison. Interesting genes are highlighted with
a special label that allows following the expression through all
the three comparisons. With this representation is possible to get
an overview on genes which show either similar or differential
expression trends in the two species. A list of the genes showing the
most significant differences is available in Table S5.
The Notch pathway. The Notch pathway is a highly
conserved cell signaling system present in most multicellular
organisms; it influences differentiation, proliferation, apoptotic
events at all stages of development, and importantly it has also
been implicated in different aspects of stem cell biology [17].
Notch controls the cell fate choices depending on the differential
expression of ligands and receptors in opposing cells. We analyzed
27 genes present in the pathway ‘‘Development Notch Signaling
Pathway’’ in GeneGo. In the comparison B vs M most of the 27
genes behaved similar in both species (Figure 3A). Our study
however identifies Notch1, one of the four known Notch receptors,
being upregulated in the mouse and downregulated in the rat in
the comparison ICM vs B as well as in ICM vs M (Figure 3A).
Thus, Notch1 is upregulated in the mouse ICM but downregulated
in the rat ICM (Figure 3B). Activated Notch1 can promote,
depending from the context, either differentiation processes or
maintenance of stem cell proliferation (reviewed in [17,18]).
Therefore, due to its variety of molecular functions, the finding
that Notch1 is differentially expressed in the mouse and rat
preimplantation embryos, especially in the cells of the ICM,
suggests a possible different role of this gene in the two species.
We also observed significant changes in the expression levels of
other 5 genes: Aph1a, Jag1, Maml1, Tle2, and Tle4 (Figure 3B). The
gene Aph1a was upregulated in the mouse but only slightly
changed in the rat in the comparison B vs M (Figure 3A and Table
S3). This gene encodes the membrane protein APH-1 that is an
essential member of the c-secretase, which cleaves single-pass
transmembrane proteins at residues within the transmembrane
domain. APH-1a is the major mammalian APH-1 isoform
required for Notch signaling during embryogenesis [19].
Interestingly, the Notch ligand Jag1 was downregulated during
the transition from morula to blastocyst stage in both species, but
this downregulation was stronger in the rat embryos than in the
mouse (Figure 3A). The gene Maml1 is involved in the regulation
of the transcriptional activation of Notch target gene expression.
Maml1 was strongly upregulated in the mouse in the comparison B
vs M and ICM vs M (Figure 3A) indicating that Maml1 expression
increases from the morula to the blastocyst stage. In the rat
however, Maml1 was specifically upregulated in the cells of the
ICM (Figure 3B) highlighting once more a potentially different
activation of the Notch pathway in the two species.
The most important targets of the Notch1-complex are the HES
genes, which are transcriptional repressors that rely on the general
corepressor Groucho/Transducin-like enhancer of split (TLE)
protein family [20]. Thus, TLE corepressors represent a key
effecter of the Notch pathway. We found that in the comparison B
versus M, Tle2 and Tle4 have a similar expression patterns in the
rat and in the mouse (Figure 3A). However, in both the
comparisons ICM vs B and ICM vs M Tle2 and Tle4 were
downregulated in the rat, indicating a specific downregulation in
the ICM cells (Figure 3B). These findings are in agreement with
the observation that Maml1, the regulator of the transcriptional
activation of Notch target gene expression is upregulated in the rat
ICM. Of interest is that Notch1 and its ligands, Jagged1, Jagged2,
and Delta3, are known to be expressed in mouse ES cells.
Overexpression of Notch does not alter the stem cell phenotype in
the presence of self-renewal stimuli, but upon their withdrawal,
differentiation is directed exclusively towards the neural lineage
[21].
These data clearly show that the control of the regulation of the
Notch pathway components in mouse and rat occurs at different
levels. In the mouse where the expression of Notch1 is relatively
high the regulation occurs by activation of inhibitory components
like Maml1 and Tle2/4 whereas in the rat the pathway is
transcriptionally inactive. It could therefore be important in order
Figure 1. Mouse and rat late preimplantation embryo development: a cross species analysis. A. Schema of mouse and rat embryo
development length. M: morula stage embryo; B: blastocyst stage embryo. E: embryonic day. B. Schema of the three cell populations used for the
cross species analysis of gene expression. The blastocyst embryo consists in the inner cell mass (ICM) and in the trophoblast cells. Embryonic stem
cells (ESCs) are derived in vitro from the ICM cells. C. Numbers of embryos collected for the whole genome expression analysis. D. Schematic
overviews of the screening strategy used in this study. M1 and M2: pool 1 and pool 2 of morula stage embryos; B1 and B2: the two pools of
blastocysts; ICM 1 and ICM2: the two pools of isolated ICMs. B vs M: blastocyst versus morula; ICM vs B: ICM versus blastocyst; ICM vs M: ICM versus
morula.
doi:10.1371/journal.pone.0047107.g001
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Figure 2. Global significant analysis. A. Mouse B. Rat heatmaps. The genes are selected by the highest fold change –20 genes in each pair wise
comparison of sample means. M1 and M2: morula samples 1 and 2; B1 and B2: blastocyst samples 1 and 2; ICM1 and ICM2: isolated inner cell mass
(ICM) cells samples 1 and 2. C–F. Venn diagrams of the overlap of mouse and rat genes with significant differential expression (fold change higher
than 1.5 and higher than 3) in the three comparisons: ICM versus (vs) Blastocyst, Blastocyst versus Morula, and ICM versus Morula.
doi:10.1371/journal.pone.0047107.g002
Pluripotency Genes in Mouse and Rat Embryos
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to enhance the efficiency of rat ESC derivation to inhibit the
Notch pathway activity.
Analysis of regulators of the cell cycle. As previously
mentioned there are strong differences during the preimplantation
development of mouse and rat embryos. Mouse embryos need
around three days to reach the blastocyst stage, what leads to
a mean cell division time during this period of about 14 h [22]. In
reality every cell division cycle during the preimplantation
development has different lengths (reviewed by [23]). Of especial
importance is the generation at the morula stage of blastomeres,
which differ in size and cell division dynamic, and at the blastocyst
stage they differentiate into trophoblast and the ICM cells. A
typical characteristic of ESCs, isolated from the ICM, is that they
exhibit an exceptional cell cycle distribution, where the S phase
Figure 3. Cross species analysis of the genes in the Notch pathway. A. Fold change scatterplots. Cross species comparison of the fold
change expression of the genes in the pathway ‘‘Development, Notch Signaling Pathway’’ from GeneGo. In green are marked the genes for which
fold change differ in mouse and rat within the three comparisons: Blastocyst versus (vs) Morula, ICM versus Blastocyst, and ICM versus Morula. In red
are marked those genes that have a similar fold change pattern in the two species in each comparison. With a special marker there are highlighted 6
selected genes that have differential expression patterns in the two species. The complete list of all the genes analyzed with their fold changes is
reported in Table S3. B. Expression signal profile plots. Expression level of 6 selected genes from the Notch pathway. In blue are marked the
expression levels of the genes in the mouse and in red the one in the rat embryos. MO: Morula, ICM: Inner cell mass, BL: Blastocyst. The unit is log2 of
measured expression.
doi:10.1371/journal.pone.0047107.g003
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represents about 75% of the total cell cycle and the G1 phase last
for about 1 h [24]. In the rat the formation of the blastocyst is
almost 24 h delayed compared to the mouse, the reason why the
rat blastomeres are dividing slower than the mouse ones is largely
unknown. In order to elucidate the events linked with cell cycle
progression in both species we analyzed 11 genes of the GeneGo
pathway ‘‘Cell cycle Influence of Ras and Rho proteins on G1/S
Transition’’ that clearly showed differential expression in the three
cell populations (Table S3).
The gene cyclin D1 (Ccnd1) showed different expression pattern
in the mouse and the rat preimplantation embryos. The Ccnd1 was
downregulated for the mouse and upregulated for the rat in both
the comparisons B vs M and ICM vs M (Figure 4A). Thus, Ccnd1
expression in the mouse decreases in the blastocyst and is even
stronger reduced in the cells of the ICM compared to the whole
blastocyst (Figure 4B). On the contrary Ccnd1 in the rat embryo is
strongly upregulated from the morula to the blastocyst, reaching
the highest expression level in the ICM cells (Figure 4B). CCND1,
in complex with CDK4/6, phosphorylates during the S phase
transition the product of the retinoblastoma (Rb). Rb is involved in
the initiation of DNA replication through the activation of E2F,
which in turn activates the transcription of cyclin E1 (Ccne1) [25].
We observed an upregulation of Rb in the mouse for the
comparisons B vs M and ICM vs M and a downregulation in
the comparison ICM vs B (Figure S2A), indicating an increase in
Rb expression from the morula stage to the blastocyst stage (Figure
S2B). The expression of Ccne1 in both species showed a similar
expression pattern during the development from morula to
blastocyst stage embryo (Figure 4B).
Skp2 (S-phase kinase-associated protein 2) is a component of the
ubiquitin ligase complex SCF, which is responsible for the
ubiquitin-dependent degradation of regulators of the cell cycle.
Precisely, Skp2 is involved in the degradation of the Cyclin-
dependent kinase (Cdk) inhibitor p27 [26], inducing therefore cell
cycle progression. p27 prevents cell cycle progression by inhibiting
the Cyclin E-Cdk2 complex formation; in the presence of the
Skp2-SCF complex p27 is degraded leading to the activation of the
Cyclin E-Cdk2 complex, which causes the entrance into the S
phase.
The expression of Skp2 was for the mouse downregulated in
both the comparisons B vs M and ICM vs M (Figure 4A) showing
a similar expression trend like Ccne1: Downregulation from the
morula to the blastocyst stage, with specific low expression level in
the ICM cells (Figure 4B). Interestingly, the expression of Skp2 in
the rat was higher in the cells of the ICM (Figure 4B).
During mitosis the cells undergo profound changes in the
microfilament structure. The myosin regulatory light chains (Myls)
control these morphological changes through their phosphoryla-
tion [27,28]. The phosphorylation of Myls is controlled by the
myosin light chain kinases (Mylks). It has been shown that the Rho
kinases (ROCK) are also involved in the phosphorylation of Myls
[29,30]. The phosphorylation sites on the Myls vary during the cell
cycle progression, inducing their activation or inhibition [31,32].
Interestingly, the expression of Myl9, Mylk, Mylk3, and Rock2 was
differentially regulated within the three comparisons in both
species (Figure 4A and 4B), demonstrating once more essential
differences between mouse and rat preimplantation development.
c-MYC plays important roles in various physiological processes
like cell growth, proliferation, apoptosis, and loss of differentiation
[33]. In the comparisons B vs M and ICM vs M c-Myc was
downregulated in both species, however in a more remarkable
manner in the rat (Figure 4A). Interestingly, the expression of c-
Myc was specifically downregulated in the rat ICM, while it was
not changed in the two compartments of the mouse blastocyst
(Figure 4B). This is interesting, since c-Myc represents an important
factor in stem cell biology; moreover it is able in vitro in
combination with three other transcription factors (Oct3/4, Sox2,
and Klf4) to reprogram differentiated cells into pluripotent cells
[34]. This expression difference might indicate that eventually an
increase of the expression of c-Myc might be necessary for
enhancing the establishment of rat ESCs.
Furthermore, in the analysis of the pathway ‘‘Cell cycle
Influence of Ras and Rho proteins on G1/S Transition’’ we
identified two members of the phosphoinositide-3-kinase pathway
(PI3K-AKT): The regulatory subunit 1 (Pik3r1) and 3 (Pik3r3).
Interestingly, in the rat both genes were specifically downregulated
in the cells of the ICM (Figure 4A and 4B). The PI3K-AKT
pathway has been implicated in many cellular processes like
regulation of cell cycle progression, apoptosis, migration, and cell
adhesion. We performed the cross species analysis on the pathway
‘‘Development Growth hormone signaling via PI3K/AKT and
MAPK cascades’’ from GeneGo (Figure S3A), where we analyzed
the expression of Pik3r1 and Pik3r3 together with other members of
the PI3K-AKT pathway (Figure S3B). The expression of Gsk3b
was found similarly regulated in both species (Figure 4A).
Nevertheless, in the rat Gsk3b was specifically downregulated in
the cells of the ICM (Figure 4B). It has been shown that authentic
rat ESC can be derived and maintained in culture only in the
presence of a GSK3b inhibitor [3]. On the contrary, pluripotent
mouse ESCs can be established and maintained also under other
culture conditions [5,35,36]. Our data report a downregulation of
Gsk3b in the cells of the ICM in the rat but not in the mouse,
letting assume that a low level of Gsk3b is fundamental in the rat
for maintaining the pluripotent state in vivo as well as in vitro. This
could indicate why the use of Gsk3b inhibitors is essential for the
establishment and cultivation of rat ESCs [3] and rat induced
pluripotent stem cells [37,38]. Optimizing the concentration of
GSK3 inhibitors could therefore positively influence the efficiency
of generation of pluripotent stem cells in the rat.
Another important signaling that influences the cell cycle is the
p53 pathway (Figure S2A and S2B). Interestingly, the gene p53
(known in the mouse as Trp53 and in the rat as Tp53) was
upregulated in the rat in both the comparisons ICM vs M and B vs
M (Figure S7A), whereas in the mouse the expression was constant
in all the three cell populations (Figure S7B). This could explain
why in the rat the gene Nqo1 (responsible for the degradation of
p53) was strongly upregulated in the ICM (Figure 2F and Table
S2A). Other genes involved in the regulation of cell proliferation
are reported in the Figure S4, where we performed the cross
species analysis on the pathway ‘‘Development SSTR2 in
regulation of cell proliferation’’ from GeneGo.
During embryo development, the proliferation kinetics of the
cells affects their fate determination, so that different cell lineages
show faster or longer cell cycle progression [23]. Also in the ESCs
in vitro a rigorous regulation of the cell cycle is fundamental for the
maintenance of pluripotency. This study makes apparent that
critical factors involved in the cell cycle and proliferation are
differentially expressed in the morula and the blastocyst of mouse
and rat. The optimal control of the expression/activity of these
genes seems therefore to be essential for the establishment and
maintenance of pluripotent ESCs from both rat and mouse.
Mouse ESCs cultivated under 2i conditions are composed of
a homogenous population of cells expressing the classical
pluripotency markers. Interestingly, it was recently shown that
when rat ESCs are cultivated under the same conditions in
presence of LIF a heterogenous population of cells is present and
these cells exhibit differences in the expression of genes that are
implicated in cell cycle regulation and in the p53 pathway [39].
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This leads to the conclusion that a tight control of the cell cycle is
mandatory for obtaining a homogenous population of pluripotent
cells in the rat.
The TGF and the Wnt signaling. The pathways transform-
ing growth factor b (TGF-b) and Wingless (Wnt) are evolutionary
conserved. The transforming growth factor–b (TGF-b) superfam-
ily comprises nearly 30 growth and differentiation factors that
include TGF-bs, activins, inhibins, and bone morphogenetic
proteins (BMPs). Members of the Nodal/Activin and BMP
subfamilies are key players in the generation of axes and in the
subsequent patterning of tissues across these axes during embryo-
genesis (for a review see: [40,41]). Similarly important are the
members of the Wnt pathway, which are active during most
developmental stages (for a review see: Kemp et al 2007).
Although, their role is not yet clear during the preimplantation
development they have been shown to be essential in maintenance
of pluripotency in mouse ESCs [42,43,44]. Therefore we included
this pathway in our cross-species analysis.
We analyzed 112 genes present in the pathway ‘‘Cytoskeleton
remodeling TGF, WNT and cytoskeletal remodeling’’ from
GeneGo. We highlighted 8 genes, which had a clear differential
expression changes between the three comparisons and between
the two species (Figure 5A and 5B).
Wnt signals are transduced depending on their functions
through different receptors and members: The canonical Wnt
pathway is known to be involved in transmitting signals for cell fate
determination, whereas the non-canonical Wnt pathway is in-
volved in controlling cell movements and tissue polarity. The gene
caveolin 1 (Cav1) was downregulated in the blastocyst and ICM cells
of the mouse (Figure 5A), whereas it was almost not expressed in
the rat cells (Figure 5B). Cav1 is an essential component of the
caveolae, where it acts as a regulator of caveolae-dependent lipid
trafficking and endocytosis [45,46]. Cav1 can act as a positive as
well as a negative regulator of important signaling pathways
(reviewed in [47]), for example it negatively regulates the Wnt
pathway by recruiting b-catenin and therefore blocking the
transcription of the b-catenin target genes [48]. The two
membrane receptors frizzled homolog 4 (Fzd4) and frizzled homolog 5
(Fzd5) were upregulated in our analysis in the mouse ICM and
blastocyst compared to the morula (Figure 5A). However, in the
rat we detected a very low expression of both receptors in all the
three cell populations (Figure 5B). This indicates that the Wnt
pathway is differentially active in the two species (see also Figure
S5). The gene Axin2 is a downstream target of the Wnt pathway
that acts as a negative regulator by directing b-catenin for
proteasomal degradation [49]. It has been shown that stable b-
catenin and elevated Axin2 transcription indicates the activation of
the Wnt pathway [50]. In our cross species analysis Axin2 was
upregulated in the mouse in both the comparisons B vs M and
ICM vs M (Figure 5A), indicating a higher expression in the cells
of the blastocyst and of the ICM (Figure 5B). Interestingly, in the
rat the expression of Axin2 decreased specifically in the cells of the
ICM (Figure 5B). The three regulators of the Wnt pathway,
namely b-catenin (Figure S2B), Axin2 (Figure 5B), and the Gsk3b
(Figure 4B) had a similar expression pattern in the rat embryos: A
reduced expression in the ICM cells compared to the morula and
whole blastocyst cells. In the mouse embryos the expression of
these three factors was almost constant except for Axin2 that was
upregulated in the ICM and blastocyst compared to the morula.
This might indicate that in the rat the Wnt signaling pathway, and
especially b-catenin could not play a major role in the maintenance
of pluripotency in rat ESCs, which is indeed the case for mouse
ESCs [42,43,44].
Interestingly, these differences are also present in other Wnt-
and TGF-pathway genes involved in the apoptotic and survival
processes. We analyzed 13 genes from the pathway ‘‘Apoptosis
and survival NGF signaling pathway’’ (Figure S6A and S6B) and
20 genes from the pathway ‘‘Apoptosis and survival Apoptotic
Activin A signaling’’ (Figure S7A and S7B) from GeneGo. For
example the apoptosis related gene Caspase3 (Casp3) was upregu-
lated in the rat in all the three comparisons (Figure S6A) indicating
a higher expression in the cells of the blastocyst (Figure S6B). On
the contrary in the mouse, Casp3 was upregulated in the cells of the
morula and then the expression decreased in the blastocyst (Figure
S6B). Combined with the observation that mouse ESCs lacking
the Casp3 gene show impaired differentiation capacity [51], our
data suggest that employing Caspase inhibitors during derivation
and cultivation of rat ESCs might be helpful.
Cross Species Analysis of the Expression Patterns of
Selected Gene Families
Based on the genes present on GeneChipHMouse Genome 430
2.0 arrays and, for the rat on the GeneChipH Rat Genome 230 2.0
arrays, we selected the families of genes. With the same approach
used for the analysis of the pathways in the morula and in the
blastocyst stage, we further characterized the expression pattern of
the genes in the three cell populations for the mouse and for the
rat. The complete list of the selected families of genes as well as the
fold changes in the three comparisons are listed in Table S4.
The BMP-ligands and -receptors family with the
intracellular SMADs-family. The bone morphogenetic pro-
teins (BMPs) are members of the transforming growth factor
(TGF) super-family and are involved in a variety of processes
during embryo development like in the generation and mainte-
nance of organs, in which stem cells play important roles. The
signaling pathway starts when the secreted BMP proteins bind to
the type I and type II BMP receptors, inducing the activation of
the intracellular substrates, the SMAD proteins.
Here we analyzed the expression of 10 BMP proteins, 4 BMP
receptors, and 6 SMAD proteins in the morula, the blastocyst and
the isolated ICM, from the mouse and from the rat (Table S4).
The genes Bmp15 and Bmp4 showed in both species the same
expression pattern: Being the former downregulated and the latter
upregulated in both the comparisons B and ICM vs M (Figure 6A).
This indicates that Bmp15 is prevalently expressed in the cells of
the morula whereas Bmp4 is upregulated in the cells of the
blastocyst and ICM. It is interesting to note that in vivo the
pluripotent cell population (ICM) of the rat and the mouse has
a similar expression of Bmp4. It has been shown that in vitro, mouse
ESCs can be maintained in serum-free culture in the presence of
BMP4 or BMP2 in combination with LIF [36]. Nevertheless,
withdrawal of LIF and retention of BMP4/2 causes differentiation
Figure 4. Cross species analysis of cell cycle component. A. Fold change scatterplots. Cross species comparison of the fold changes
expression of the genes in the pathway ‘‘Cell cycle, Influence of Ras and Rho proteins on G1/S transition’’ from GeneGo (see also Table S3). The data
were analyzed as described in Figure 3A. Thirteen genes have been highlighted in order to follow their expression in the three comparisons. B.
Expression signal profile plots. Expression level of 13 selected genes involved in the regulation of the cell cycle. In blue are marked the expression
level of the genes in the mouse and in red the one in the rat embryos. MO: Morula, ICM: Inner cell mass, BL: Blastocyst. The unit is log2 of measured
expression.
doi:10.1371/journal.pone.0047107.g004
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into epithelial-like cells, leading to the conclusion that the self-
renewal response to BMP is dependent on continuous LIF
signaling and that the BMP main function is to antagonize the
neural differentiation induced by LIF in the absence of serum [36].
All the attempts to derive rat ESCs in serum-containing medium
failed in the last years so that nowadays it is possible to establish rat
Figure 5. Cross species analysis of the genes in the Wnt and TGF pathways. A. Fold change scatterplots. Cross species comparison of the
fold changes expression of the genes in the pathway ‘‘Cytoskeleton remodeling, TGF, WNT and cytoskeletal remodeling’’ from GeneGo (see also Table
S3). The data were analyzed as described in Figure 3A. Eight genes have been marked with a special label. B. Expression signal profile plots.
Expression level of the 8 selected genes in the morula, the ICM, and the blastocyst in the mouse (blue) and in the rat (red). MO: Morula, ICM: Inner cell
mass, BL: Blastocyst. The unit is log2 of measured expression.
doi:10.1371/journal.pone.0047107.g005
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ESCs only under defined, serum-free conditions [3]. Therefore,
seen that the expression of Bmp4 in the ICM of the mouse and the
rat blastocyst is similar, it would be interesting to carefully examine
the role of BMP4 in rat ESC derivation and maintenance. The
expression analysis of other Bmp-ligands revealed a general
upregulation in the mouse and downregulation in the rat
(Figure 6A) whereas no major differences in the two species could
be observed for the Bmp receptors (Figure 6B). In the comparison
ICM vs M the sole gene that was differentially expressed between
mouse and rat was Bmpr1a that was upregulated in the rat but did
not have differential expression in the mouse (Figure 6B).
In the BMP signaling pathway the activated receptors recruit
the SMAD molecules, which transmit the signal from the cell
surface to the nucleus (Table S4). The expression of the receptor-
regulated Smad1, 22, 23 had a similar expression pattern in both
the species in all the three comparisons (Figure 6C). The products
of these genes are transcription factors that form complexes with
SMAD4 and regulate gene transcription. The expression of Smad4
increased in the mouse in all the compartments of the blastocyst
(Figure 6C) whereas in the rat expression of Smad4 persisted from
the morula to the blastocyst but was specifically upregulated in the
cells of the ICM (Figure 6C). In the comparisons ICM vs B and
ICM vs M the expression of Smad7 (inhibitory Smad) was in both
cases downregulated in the mouse but upregulated in the rat cells
(Figure 6C). It is interesting to notice, that in the mouse we
observed an upregulation of the transcription factors Smad3 and
Smad2 (receptor regulated Smads) in the cells of the ICM and the
blastocyst, together with an upregulation of the Co-regulator
Smad4, whereas the expression of Smad7 was specifically down-
regulated in the ICM (Figure 6E).
Analysis of the pathway called ‘‘Development BMP signaling’’
from GeneGo revealed that other genes involved in this pathway
are differentially regulated in the morula, ICM, and blastocyst of
the mouse and the rat (Figure 6D). The BMP pathway plays
important roles in the differentiation of ESCs in vitro. Rat ESCs
seems to be more sensitive to differentiation stimuli than mouse
ESCs, therefore the differential regulation observed in vivo of the
factors involved in this pathway might reflect also a differential
expression in vitro, in mouse and rat ESCs.
The FGF-factors and FGFR-receptors family. The fibro-
blast growth factor (FGF) ligands and receptors have been
implicated in different phases of the early embryogenesis [52].
The FGF signaling controls proliferation and differentiation of the
cells, cell survival, cell morphology and migration, through the
activation of important cytoplasmic signal transduction pathways
like for example the Ras/ERK pathway and the AKT pathway
[53,54].
We analyzed the expression in the three cell populations of 21
FGF factors and 7 cell surface FGF receptors present on the mouse
and the rat microarray chip (Table S4). The expression of Fgf4 was
constant in the mouse morula and blastocyst, in the rat embryos
however, Fgf4 expression was upregulated in the comparison B vs
M and downregulated in the ICM vs B (Figure 7A). Thus, the
expression of Fgf4 in the rat preimplantation embryo is low in the
ICM cells but higher in the trophoblast cells of the blastocyst. This
observation is interesting, since rat trophoblast stem (TS) cells are
FGF4-dependent [55]. The gene Fgfr4 was in the mouse down-
regulated in both the comparisons ICM vs B and ICM vs M,
indicating an expression in the morula and trophoblast cells of the
blastocyst (Figure 7B), its expression was however not changed in
the rat cell populations. The expression of Fgfr2 increased for both
species in the blastocyst, although the upregulation was more
predominant in the rat than in the mouse (Figure 7B). The analysis
of the pathway ‘‘Development FGFR signaling pathway’’ from
GeneGo also highlighted differential expression patterns of genes
in the two species (Figure 7C). For example the expression of the
gene Raf1 was similar in the cells of the morula in the mouse and
in the rat. However, for the mouse it was downregulated in the
ICM cells and upregulated in the whole blastocyst, whereas for the
rat it was upregulated in the ICM and downregulated in the whole
blastocyst (Figure 7D). Raf1 is a member of the MAPK/ERK
pathway (mitogen-activated protein kinase/extracellular receptor
kinase), which is stimulated by the FGF factors during embryo
development. In a previous study the expression of Raf1 was
detected in both the ICM cells and the trophoblast cells of the
mouse blastocyst in a similar amount [56]. We measured however,
a downregulation of Raf1 expression in the ICM cells and an
upregulation in the trophoblast cells of the blastocyst. This is in
agreement with its involvement in the activation of the FGF
signaling that is responsible for the maintenance of the trophoblast
cells. Interestingly, the expression of Raf1 in the rat was
downregulated in the trophoblast cells (Figure 7D) and upregu-
lated in the ICM cells, leading to the assumption that this member
of the MAPK pathway plays a role in the ICM cells of the rat
blastocyst. We further analyzed 13 members of the MAPK family
and we found differences in the expression of several genes in the
three cell populations of the mouse and the rat (Figure S8A and
Table S4). These data suggest that a tight control of the MAPK/
ERK pathway members with small chemical compounds might
improve the establishment and derivation of pluripotent rat stem
cells.
The Wnt-ligands family. We have already reported some
important changes in the expression of members of the Wnt
pathway (Figure 5 and Figure S5). Here we analyzed 17 members
of the Wnt-secreted factors and interestingly, we observed that the
expression of many Wnt genes is differentially regulated in the
mouse and in the rat (Table S4). For example Wnt6 was
upregulated in the trophoblast cells of the mouse blastocyst
whereas it was upregulated in the cells of the morula in the rat
embryos (Figure 8A). The opposite expression pattern was
observed for the gene Wnt4, that was upregulated in the mouse
in the morula and in the rat in the blastocyst cells. Interestingly, in
the rat Wnt5a was highly expressed in the cells of the morula and
in a lesser extend in the ICM cells (Figure 8A), whereas in the
mouse its expression showed only minor differential regulation
between the three comparisons (Table S4). The role of the Wnt5a
ligand has been extensively studied since it acts through both the
canonical and non-canonical Wnt pathway [57]. Importantly, the
canonical Wnt pathway has been implicated in the maintenance of
pluripotency in mouse ESCs. The WNT5A ligands, together with
WNT6, WNT3, and WNT3A were reported to be sufficient for
maintaining mouse ESCs in an undifferentiated state in the
absence of LIF [58]. Although the precise mode of action of the
Wnt pathway in maintaining pluripotency in ESCs needs still to be
clarified, it is important to note that factors like Wnt5a and Wnt6
are differentially regulated in the mouse and in the rat in the
pluripotent cell compartment of the blastocyst (Figure 8A and
Table S4). Further studies will be necessary for clarifying the
respective function of these genes in the establishment of the
pluripotent cells during preimplantation development.
The Stat family. The Signal transducer and activator of
transcription (STAT) proteins are cytoplasmic transcription factors
that transmit the information received from the transmembrane
receptors directly to the nucleus of the cells, where they target the
promoter of genes involved in survival, proliferation, and
differentiation [59]. Here we analyzed the expression of 5
members of the STAT family (Figure 8B and Table S4). The
type I interferons (IFN) are involved in antiproliferative, apoptotic,
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and antiviral processes, and they are responsible for the activation
of STAT1 and STAT2 [60]. In the rat Stat2 was upregulated in
the blastocyst cells, however in the mouse Stat2 expression
decreased from the morula to the blastocyst stage (Figure 8B).
The Stat6 expression was upregulated in the rat in the cells of the
morula, whereas it did not show differential expression in the
mouse cell populations (Figure 8B).
In the comparison ICM vs B all the Stats showed a similar
expression in the mouse and in the rat. Only Stat5a and Stat5b were
differentially regulated, being the former higher expressed in the
trophoblast cells of the mouse blastocyst whereas the latter was
upregulated in the trophoblast cells of the rat blastocyst (Figure 8B).
This analysis showed that members of the Stat family are
differentially regulated in the mouse and rat preimplantation
embryos, advising a possible different implication in the de-
velopment of the morula and blastocyst in the two species.
Interestingly in contrast to mouse ESCs, rat ESCs even if derived
and cultivated under 2i conditions are LIF dependent. Our data
highlights the importance to further analyze the exact role of LIF
and other cytokines able to activate STAT-family members during
rat development and pluripotent stem cell derivation.
Expression Pattern Analysis of Genes Related to
Pluripotency
The goal of this study was to give a general overview on the
regulation of the molecular mechanisms that take place during the
development of the mouse and the rat preimplantation embryo
form the morula to the blastocyst stage, in order to highlight
similarities and differences that could help in the derivation and
maintenance of rat ESCs. The LIF/gp130 pathway that leads to
the activation of the transcription factor STAT3, plays a funda-
mental role in the maintenance of pluripotency in mouse ESCs
[8,9,10,35,61] as well as in rat ESCs [3,4]. Controversially, ESCs
show LIF dependence (under certain culture conditions), whereas
early epiblast cells do not require LIF stimulation. In fact, Lif2/2
embryos develop into later stages [7] and embryos carrying
mutations on the LIFbR and gp130 receptor develop normally, at
least until mid-gestation [62,63]. Nevertheless, the LIF/STAT3
pathway is indispensable during the preimplantation development,
in case of diapause [64]. This observation could explain why
embryos do express all the component of this pathway and
moreover, why ESCs that are directly derived from the ICM of the
blastocyst, are LIF-dependent (reviewed in [65]). Due to the
importance of the LIF/gp130-STAT3 pathway in the mainte-
nance of pluripotency in ESCs, we selected 11 genes involved in
this pathway and we analyzed their expression in the mouse and
rat morula, blastocyst, and ICM.
Interestingly, the expression of Lif increased in the mouse from
the morula to the blastocyst, having a lower expression in the cells
of the ICM. On the contrary, in the rat its expression was stable in
the ICM cells as well as in the whole blastocyst (Figure 9A). A
behavior similar in the two species was observed for Jak2 that was
specifically downregulated in the ICM but upregulated in the
blastocyst (Figure 9A). Jak1 expression indeed, showed in the
mouse an analog expression pattern like Lif, whereas in the rat it
was specifically downregulated in the cells of the ICMs (Figure 9A).
The binding of the cytokine LIF to the receptor results in the
heterodimerization of the LIFbR and gp130 that causes the
activation of receptor-associated JAKs, which are responsible for
the phosphorylation and activation of STAT3. JAK1 is necessary
for the transmission of the LIF-induced signaling, whereas JAK2 is
dispensable. Thus, due to the higher LIF-dependence of rat ESCs
in comparison to mouse ESCs, it would be of interest to analyze
the expression of Jak1 in rat ESCs. Interestingly, also the
expression of Stat3 was reduced in the rat ICM cells compared
to the whole blastocyst, whereas in the mouse it was constant.
Nevertheless, at the morula stage both mouse and rat showed
a similar expression level of Stat3 (Figure 9B). The transcription of
the Socs genes is directly controlled by STAT3. Socs3 is responsible
for the negative regulation of the LIF/STAT3 signaling [66].
Although we observed a general upregulation in the mouse
preimplantation embryo of the components of the LIF pathway,
the expression of Socs3 was downregulated in the ICM and in the
whole blastocyst (Figure 9B). Interestingly, in the rat embryos Socs3
expression increased in a similar manner like Stat3, from the
morula to the blastocyst stage (Figure 9B) suggesting again that
a well-balanced LIF/STAT3 activation is crucial in the rat. This is
of importance for the derivation of rat ESCs indicating that despite
the need of LIF for their derivation; applying not optimal
concentration of this cytokine could reduce the efficiency of
establishment. In parallel to the activation of the STAT3 pathway,
binding of LIF to the LIFbR/gp130 receptor leads the activation
of the mitogen-activated protein kinase (MAPK) and the
phosphatidylinositol-3 phosphate kinase (PI3K) pathways. Active
gp130 receptor can associate with the protein tyrosine phosphatase
SHP-2 [67], which leads to the activation of the kinases RAS/RAF
and finally ERK1/2. The expression of Shp2 was specifically
downregulated in the rat ICM cells whereas it was upregulated in
the mouse ICM (Figure 9C). However, the expression of Raf1 had
exactly the opposite expression pattern: Downregulated in the
mouse ICM cells and upregulated in the rat ICM, indicating
a differential expression in both the ICM cells and the trophoblast
cells in the two species (Figure 9C). ERK regulates early
differentiation processes in vivo as well as in vitro [6,68], so that it
has been shown that inhibition of this pathway together with the
inhibition of GSK3 is sufficient for maintaining pluripotency in
ESCs in the absence of LIF [5].
A downstream effector of the PI3K pathway is the serine/
threonine protein kinase B (PKB, also known as AKT). AKT has
been implicated in many cellular processes like regulation of the
cell cycle progression, cell death, adhesion, migration, metabolism
and tumorigenesis. In the mouse and in the rat preimplantation
embryo we observed a similar expression pattern of Akt1, which
increased from the morula to the blastocyst stage, although in the
mouse the increase was more prominent (Figure 9C).
The genes Sox2, Klf4, and Klf2 are involved in ESCs in the
maintenance of pluripotency [69,70,71]. Moreover, Sox2 and Klf4
together with cMyc and Oct3/4 are the four factors used for
reprogramming differentiated cells into induced pluripotent stem
cells (iPSCs) [34].
Figure 6. Cross species analysis of regulators of the BMP pathway. A. The BMP protein family. Scatterplots of the fold changes measured in
the three comparisons for 9 members of the BMP protein family in the mouse and in the rat. The complete list of all the genes analyzed as well as
their fold changes are reported in Table S4. B–C. Same analysis like for the BMP proteins was performed for 4 members of the BMP receptor family
(B.) and for 6 members of the SMAD protein family (C.). D. Fold change scatterplots. Cross species comparison of the fold changes expression of the
genes in the pathway ‘‘Development, BMP signaling’’ from GeneGo (see also Table S3). The data were analyzed as described in Figure 3A. E.
Expression signal profile plots. Expression level analysis of 4 selected genes from the BMP pathway. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell
mass; BL: Blastocyst. The unit is log2 of measured expression.
doi:10.1371/journal.pone.0047107.g006
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SOX2 is a member of the sex-determining region of the Y
chromosome-related (SRY-related) high-mobility group (HMG)
box (SOX) family of transcription factors. Sox2 expression is
downregulated in cells with restricted developmental potential. We
observed an upregulation of Sox2 expression in the mouse from the
morula to the blastocyst stage (Figure 9D). Interestingly, in the rat
embryos Sox2 was expressed at lower levels compared to the
mouse; moreover it was slightly downregulated in the blastocyst
compared to the morula (Figure 9D).
Some of the Klf genes (Kru¨ppel-factors) have been proposed as
downstream targets of LIF/STAT3 pathway in ESCs [70]. In our
analysis we observed that the expression of Klf4 increased in the
cells of the rat ICM and was downregulated in the whole
blastocyst, whereas in the mouse embryos the upregulation of Klf4
was less strong in the ICM cells (Figure 9D). Also Klf2 in the rat
was upregulated in the ICM and blastocyst but it was down-
regulated in the mouse blastocyst and ICM cells (Figure 9D). This
is interesting since Klf2 and Klf4 have been implicated with
important pluripotency factors in mouse ESCs [70]. Thus, the fact
that they are differentially regulated in the morula and blastocyst
from the rat compared to the mouse, could be a contributing
factor for the differences observed between mouse and rat ESCs in
the derivation efficiency and culture conditions.
The differential expression of these factors can also be of interest
for the reprogramming rat somatic cells to pluripotency. Rat
iPSCs could be successfully established in 2008 and it could be
shown that they can differentiate into all three germ layers in vitro
and in vivo [72,73] and can contribute to generating chimeric rats
[37]. This study clearly indicated that rat iPSCs exhibit extensive
spontaneous differentiation and only by combining inhibitors of
MEK, GSK3b and of the type 1 TGFb-receptor ALK5 is possible
to stabilize the rat iPSCs cultures [37]. The need of the ALK5-
Figure 7. Cross species analysis of regulators of the FGF pathway. A–B. Scatterplots of the fold changes measured in the three comparisons
for 21 members of the FGF factor family (A.) and for 7 FGF receptors (B.) in the mouse and in the rat. The complete list of all the genes analyzed as
well as their fold changes are reported in Table S4. C. Fold change scatterplots. Cross species comparison of the fold changes expression of the genes
in the pathway ‘‘Development, FGFR signaling pathway’’ from GeneGo (see also Table S3). The data were analyzed as described in Figure 3A. D.
Expression signal profile plots. Expression level analysis of 5 selected genes from the FGFR pathway. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell
mass; BL: Blastocyst. The unit is log2 of measured expression.
doi:10.1371/journal.pone.0047107.g007
Figure 8. Cross species analysis of the Wnt ligands family and the STAT family. A–B. Scatterplots of the fold changes measured in the
three comparisons for 11 members of the Wnt family (A.) and for 5 STAT family members (B.) in the mouse and in the rat. The complete list of all the
genes analyzed as well as their fold changes are reported in Table S4.
doi:10.1371/journal.pone.0047107.g008
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inhibitor is interesting because this is in accordance with our
observations that bmp4 and smads are differentially regulated
between mouse and rat (Figure 6). Of further interest is that these
studies were not able to obtain germline competent rat iPSCs.
Germline competence could be obtained by combining MEK- and
GSK3b-inhibitors with small molecules blocking FGF receptor
tyrosine kinases [38]. Also these observations are in accordance
with our data showing that the FGF-pathway is differentially
regulated in the two species (Figure 7).
Conclusion
The higher genetic diversity of the rat compared to the mouse
[74] has made the rat an optimal animal model for the
investigation of human diseases, such as infectious and autoim-
munity diseases, or for toxicology and drug development.
Moreover, the rat has other advantages compared to the mouse
like for instance the bigger size or the higher learning capacity that
make it a convenient research animal model. Nevertheless, the
impossibility for many years to generate authentic rat ESCs has
given the mouse a clear advantage over the rat as a model for
biomedical research.
With this study we aimed at the identification of differences at
the transcriptional level between the mouse and the rat during the
embryo development in which the ICM cells are formed, since
they represent the source of ESCs derivation. The differential
regulation of critical genes could represent the starting point for
analyzing their function in vitro in mouse and rat ESCs.
Furthermore, this knowledge could be critical for the improvement
of the derivation and maintenance of rat ESCs. Although recently
rat ESCs have been generated [3,4] there are still many questions
Figure 9. Expression signal profile plots for 11 genes involved in the LIF/gp130 signaling. Expression signal profile plots. A. Expression
level analysis of Lif, which encode the ligand that binds on the LIFbR/gp130 receptor, and of Jak2 and Jak1 the receptor-associated Janus Kinases
involved in the propagation of the extracellular signaling. B. Expression level analysis of Stat3 and Socs3. The transcription factor STAT3 directly
controls the transcription of the negative regulator SOCS3. C. Expression level analysis of Shp2, Raf1, and Akt1. The products of these three genes lead
to the activation of the ERK- and PI3K/AKT-pathways. D. Expression level analysis of Sox2, Klf4, and Klf2. These genes are involved in the maintenance
of pluripotency in ESCs. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. The unit is log2 of measured expression.
doi:10.1371/journal.pone.0047107.g009
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open. A broader knowledge on the molecular mechanisms that
occur in rat ESCs would improve the efficiency of establishing
stable authentic pluripotent rat ESCs and therefore it would
facilitate the generation via gene targeting of transgenic rat
models, which are indispensable for the biomedical research. This
is the first study that investigated the gene expression changes
during the transition from morula to blastocyst in the rat
preimplantation development. Moreover, our study represents
a new example of statistical approach for cross species analysis that
could be applicable also for other species. The so-obtained data
allows highlighting the species-specific behavior of genes within
important pathways and families through the creation of own gene
networks. An example of network of genes that behave in
a different way in mouse and rat is presented in Figure 10.
We found in our study a number of differentially expressed
genes which could be relevant for improving the derivation and
maintenance of pluripotent ESCs from the rat. Even though most
of the biological processes active during the switch between
morula to blastocyst in both species were very similar (Figure S1),
a number of differences could be observed in the regulation of
specific pathways. Of particular interest is the differential
regulation of the Wnt-, Notch- and LIF/Stat3-pathway compo-
nents. An interest observation for the mouse is that the control of
these pathways occurs through the activation of inhibitory
components. An example is the high expression of inhibitory
components like Maml1 and Tle2/4 to counteract the high
Notch1 expression (Figure 3). In the rat this pathway is rather
regulated at transcriptional level by directly reducing the
expression of Notch1. Also other important genes like b-catenin,
Bmp4, or Smad4 show important expression differences. Some of
the genes were previously identified to be important factors in the
maintenance of pluripotency in ESCs, like for example Sox2 or
Stat3, or play a role in reprogramming somatic cells to
pluripotency like c-Myc, Klf4 and p53.
In summary, this study identified within important signaling
pathways interesting candidates differentially expressed in the
mouse and in the rat preimplantation embryos. We believe that
these differences observed in vivo might reflect also the differences
observed between the mouse and the rat ESCs, for instance in
their derivation efficiency and maintenance. Further analyses are
needed in order to clarify which roles do they have in ESCs, and
furthermore if they might represent new pluripotency factors. We
Figure 10. Network of selected differentially expressed genes between mouse and rat in the comparison blastocyst versus morula.
Network of selected genes that show different expression patterns in mouse and rat in the comparison blastocyst versus morula. The genes come
from the pathway and family gene lists (Table S3 and S4), the graph has been created with GeneGo network editor tool.
doi:10.1371/journal.pone.0047107.g010
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believe that this study represents a good starting point for further
analysis aimed at the specific identification of new factors related
to pluripotency in both the species.
Materials and Methods
Mouse and Rat Strains
Mouse: Hybrid B6D2F1 mice (female C57BL/66male DBA/
2). Rat: Outbreed Wistar Han rats. Animals were housed under
controlled lighting (lights on at 0600–1800 h), temperature
(2362uC) and humidity (5065%), with free access to food and
water. The Veterinary Office of the Canton of Zurich, Switzerland
approved all animal experiments. Housing and experimental
procedures were in accordance with the Swiss animal protection
law and conformed to the European Convention for the protection
of vertebrate animals used for experimental and other scientific
purposes (Council of Europe no. 123, Strasbourg 1985).
Collection of Mouse Embryos
3 to 5 weeks old B6D2F1 females were superovulated with 5IU
pregnant mare’s serum gonadotropin (PMSG) (FolligonH Intervet)
and 48 h later, with 5IU human chronicle gonadotropin (hCG)
(ChorulonH Intervet). Superovulated females were mated with
B6D2F1 males for 24 h and then housed separately to the males.
Upon isolation morula and blastocyst stage embryos were either
stored at 280uC for further RNA extraction or immunosurgery
was performed for the isolation of the inner cell masses (ICMs).
Isolation of ICMs by Immunosurgery with Mouse
Blastocyst Stage Embryos
Zona pellucida was removed by shortly incubating the
blastocysts with Tyrode’s solution (Sigma). Consequently zona-
free blastocysts were washed several times with M2 medium
(Sigma) and immunosurgery was performed, by incubating the
embryos 30 min with rabbit anti-mouse serum (Sigma). After-
wards, embryos were washed several times with DMEM medium
(GIBCO) supplemented with 10% of fetal bovine serum. The
embryos were then incubated (37Cu, 5% CO2) with guinea pig
complement serum (Sigma) for another 30 min. Rabbit anti-
mouse serum was used 1:30 diluted in DMEM medium; guinea
pig complement serum was diluted 1:3 in DMEM. The isolated
ICMs were stored at 280uC till total RNA was extracted.
Collection of Rat Embryos
6 to 12 weeks old Wistar females were check for estrus by using
the Estrus Cycle Monitor EC40 (Fine Science Tools, Foster City,
CA) as previously described [75]. All the positive females were
breaded with Wistar males for 24 h and then housed separately to
the males. At day E4 of pregnancy Wistar females were sacrificed
and morula embryos were isolated and stored for later RNA
extraction. Blastocyst embryos were isolated at E4.5 and either
collected for further RNA extraction or processed for immuno-
surgery.
Immunosurgery with Rat Blastocyst Stage Embryos
After removal of the zona pellucida, blastocysts were incubated
for 3 hours (37Cu, 5% CO2) in rabbit anti-rat serum (Sigma).
Afterwards, embryos were washed several times with DMEM
medium (GIBCO) supplemented with 10% of fetal bovine serum
and incubated with rat serum (made in-house) for 20 min (37Cu,
5% CO2). Rabbit anti-rat serum was used 1:5 diluted in DMEM
medium; rat serum was diluted 1:5 in DMEM. The isolated ICMs
were stored at 280uC till total RNA was extracted.
Total RNA Extraction From Mouse and Rat Embryos
Till the desired amount of embryos was reached, embryos were
stored in RLT buffer supplemented with 1% of b-mercaptoetha-
nol (first lyses buffer of the RNeasy Micro Kit (QIAGEN) protocol)
at 280uC. Two pools of embryos for each developmental stage
where formed (Figure 1C). Total RNA was extracted by using
RNeasy Micro Kit (QIAGEN) according to the manufactures’
recommended protocols. All RNA samples were kept at280uC till
they were processed for microarray hybridization.
Mouse and Rat Microarray Experiment Description
cRNA preparation. The quality of the isolated RNA was
determined with a NanoDrop ND 1000 (NanoDrop Technologies,
Delaware, USA) and a Bioanalyzer 2100 (Agilent, Waldbronn,
Germany). The cDNA was prepared from total RNA using
a primer mix and reverse transcriptase (RT) (WTOvation Pico
System, NuGEN, 3300-12). The primers have a DNA portion that
hybridizes either to the 59 portion of the poly (A) sequence or
randomly across the transcript. SPIA amplification, a linear
isothermal DNA amplification process, was used to prepare single-
stranded cDNA in the antisense direction of the mRNA starting
material. Single-stranded cDNA quality and quantity was de-
termined using NanoDrop ND 1000 and Bioanalyzer 2100.
Fragmented and biotin-labeled single-stranded cDNA targets were
generated with the FL-Ovation cDNA Biotin Module V2
(NuGEN, 4200-12).
Array hybridization. Biotin-labeled single-stranded cDNA
targets (5 mg) were mixed in 220 ml of Hybridization Mix
(Affymetrix Inc., P/N 900720) containing a Hybridization Con-
trols and Control Oligonucleotide B2 (Affymetrix Inc., P/N
900454). The six mouse samples were hybridized to GeneChipH
Mouse Genome 430 2.0 arrays for 18 h at 45uC the same
procedure was used for the six rat samples that were hybridized to
GeneChipH Rat Genome 230 2.0 arrays. Arrays were then washed
using an Affymetrix Fluidics Station 450 FS450 0004 protocol. An
Affymetrix GeneChip Scanner 3000 (Affymetrix Inc.) was used to
measure the fluorescent intensity emitted by the labeled target.
Processing of Microarray Data
Raw data processing was performed using the Affymetrix
AGCC software. After hybridization and scanning, probe cell
intensities were calculated and saved in appropriate CEL files. The
CEL files have been processed by scripts in R, prepared with
Bioconductor [76] libraries: affy, simpleaffy, limma, gplots and
biomaRt. Mouse CEL files have been grouped for summarization
with Brainarray [77] custom CDF file Mouse4302_Mm_ENSG
(16860 gene product summaries), while rat CEL files had the
probes grouped by Rat2302_Rn_ENSG CDF file (11462 gene
product summaries). Summarization was performed with standard
RMA algorithm [78].
Mapping of Genes between the Species
The table of mouse-rat orthologs, labeled with Ensembl gene
identifiers, has been prepared with biomart interface (http://
biomart.org) to Ensembl database [79] (Ensembl genes v60,
mouse genome NCBIM 37, rat genome RGSC 3.4). All the
mouse genes present in the Brainarray summary file have been
translated to rat orthologs, resulting in the translation table that
includes 139139 mouse genes (ca 77.9% of those in the array
summary) and 99083 rat genes (79.2% of those in the array
summary). The table has been used to map mouse genes to rat
orthologs and vice versa.
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Selection of Gene Sets from Pathways and Families
The pathways and the genes included in them have been
extracted from Metacore database via GeneGo tool (Thomson
Reuters, http://portal.genego.com, [80]). For all the pathways,
a list of genes with Ensembl identifiers has been extracted and the
genes that have mouse-rat ortholog pairs in the mapping table
have been selected. The pathways (groups of genes belonging to
the same pathway map in GeneGo Metacore database) and gene
families have been selected on the basis of the relevance to various
developmental processes. All the analyses have been repeated for
the groups of genes belonging to the selected pathways and
families. For the graphical overview of the sample processing and
data analysis see Figure 1D.
Discovering Patterns of Similarities and Differences
within Groups
For all the pairs of tissues (blastocyst versus morula, ICM versus
blastocyst, and ICM versus morula), the fold changes have been
calculated for both: mouse and rat separately. To find the genes
that have expression characteristics similar or different in each of
the pairs of samples the heuristics have been defined. All the fold
changes described in the paper are the values after log2 (sometimes
called also log2 ratio in the literature) for the sake of symmetry
of the fold change distribution and easier tracing the direction of
expression changes. The log2 values are also a typical outcome of
the algorithms summarizing Affymetrix microarray measurements
(eg. RMA). As similar are regarded genes with the difference of
fold change smaller than a specific threshold (0.2 on log2 scale).
On the scatterplots these genes are marked with red. As different
are marked those that have the absolute difference of fold changes
bigger than a threshold of 0.4, but also having both mouse and rat
fold changes absolute value bigger than a threshold of 0.2 - to
choose the genes that are not on the fold change scatterplot
diagonal, but excluding the genes not differentially expressed in
one of the specie. Genes that satisfy the ‘‘differential inter-species
fold change conditions’’ are marked green. The rest of genes that
do not fulfill ‘‘different’’ or ‘‘similar’’ condition, are marked plain
black on the scatterplot.
‘‘similar’’ pattern genes (red):
g : DFCmouse(g){FCrat(g)Dv0:2
‘‘different’’ pattern genes (green):
g : DFCmouse(g){FCrat(g)Dw0:4 ^ DFCmouse(g)Dw0:2^
DFCrat(g)Dw0:2
Supporting Information
Figure S1 Most significantly enriched Gene Ontology
Biological Process terms according to GeneGo. The lists of
genes counted for the enrichment are those that have been used
for the Venn diagram with 1.5 fold change differences.
(TIF)
Figure S2 Cross species analysis of the genes in the p53
pathways. A. Fold change scatterplots. Cross species comparison
of the fold changes of the genes of the pathway ‘‘Transcription,
p53 signaling pathway’’ from GeneGo (see also Table S3). The
data were analyzed as described in Figure 3A. B. Expression signal
profile plots. Expression pattern analysis of 4 genes from the p53
pathway. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell
mass; BL: Blastocyst.
(TIF)
Figure S3 Cross species analysis of PI3K/AKT and
MAPK cascades. A. Fold change scatterplots. Cross species
comparison of the fold changes of the genes in the pathway
‘‘Development, growth hormone signaling via PI3K/AKT and
MAPK cascades’’ from GeneGo (see also Table S3). The data
were analyzed as described in Figure 3A. B. Expression signal
profile plots. Expression pattern of 6 selected genes. Mouse: blue;
Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst.
(TIF)
Figure S4 Cross species analysis of factors involved in
the regulation of cell proliferation. A. Fold change
scatterplots. Cross species comparison of the fold changes of the
genes in the pathway ‘‘Development, SSTR2 in regulation of cell
proliferation’’ from GeneGo (see also Table S3). The data were
analyzed as described in Figure 3A. B. Expression signal profile
plots. Expression pattern of 3 selected genes. Mouse: blue; Rat:
red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst.
(TIF)
Figure S5 Cross species analysis of the Wnt pathway. A.
Fold change scatterplots. Cross species comparison of the fold
changes of the genes in the pathway ‘‘Development, WNT
signaling pathway. Part 2’’ from GeneGo (see also Table S3). The
data were analyzed as described in Figure 3A. B. Expression signal
profile plots. Expression pattern of 6 selected genes. Mouse: blue;
Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst.
(TIF)
Figure S6 Cross species analysis of apoptotic processes.
A. Fold change scatterplots. Cross species comparison of the fold
changes of the genes in the pathway ‘‘Apoptosis and survival, NGF
signaling pathway’’ from GeneGo (see also Table S3). The data
were analyzed as described in Figure 3A. B. Expression signal
profile plots. Expression pattern of 4 selected genes. Mouse: blue;
Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst.
(TIF)
Figure S7 Cross species analysis of apoptotic processes.
A. Fold change scatterplots. Cross species comparison of the fold
changes of the genes in the pathway ‘‘Apoptosis and survival,
Apoptotic Activin A signaling’’ from GeneGo (see also Table S3).
The data were analyzed as described in Figure 3A. B. Expression
signal profile plots. Expression pattern of 5 selected genes. Mouse:
blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst.
(TIF)
Figure S8 Cross species analysis of MAPK family. Fold
change scatterplots. Scatterplots of the fold changes measured in
the three comparisons for 12 members of the MAPK family in the
mouse and in the rat. The complete list of all the genes analyzed as
well as their fold changes are reported in Table S4.
(TIF)
Table S1 Mouse Venn diagram 1.5 fold change gene list.
A. ICM versus Blastocyst, B. Blastocyst versus Morula, C. ICM
versus Morula.
(XLS)
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Table S2 Rat Venn diagram 1.5 fold change gene list. A.
ICM versus Blastocyst, B. Blastocyst versus Morula, C. ICM
versus Morula.
(XLS)
Table S3 Pathway analysis. List of genes and fold changes in
the mouse and in the rat for the three comparisons (blastocyst
versus morula, ICM versus blastocyst, ICM versus morula).
(XLS)
Table S4 Gene family analysis. List of genes and fold
changes in the mouse and in the rat for the three comparisons
(blastocyst versus morula, ICM versus blastocyst, ICM versus
morula).
(XLS)
Table S5 Summary of differentially regulated genes
between mouse and rat in the pathways analyzed.
(XLS)
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